In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

SRA's number for the day: 572

This article was originally published in SRA

The US Food and Drug Administration receives up to 572 medical device protocols involving pediatrics every year1.

The figure is based on the average number of applications or submissions, including supplements, reviewed by the FDA's Center for Devices and Radiological Health per year and an estimate on the per cent of medical device applications involving children.

The FDA released this figure on 26 February, when it made substantive changes to a 2001 interim rule on providing additional safeguards for children participating in clinical investigation of drugs, medical devices and other products. The new rule will start applying from 28 March.

In 2001, the agency received 170 medtech pediatric protocols. Since then, such submissions have ranged between 305 and 572 per year, it said. These medtech pediatric studies, as well those involving drugs, biologics, food and food additives involving children (totaling around 872 to 1,227 per year) will be affected by the new rule.

References

1. Federal Register, 26 February 2013, 78(38), 12937-12951, www.gpo.gov/fdsys/pkg/FR-2013-02-26/pdf/2013-04387.pdf

Latest Headlines
See All
UsernamePublicRestriction

Register

MT039914

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel